Yoshio Kiyohara

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Alexander Eggermont, Christian U. Blank, Mario Mandalà et al. · The Lancet Oncology · 2021 · 364 citations · Full text

Surgical Oncology, Medicine, Melanoma +8

A proposal for a TNM staging system for extramammary Paget disease: Retrospective analysis of 301 patients with invasive primary tumors

Kuniaki Ohara, Yasuhiro Fujisawa, Koji Yoshino et al. · Journal of Dermatological Science · 2016 · 148 citations

Surgical Oncology, Tnm Staging System, Tumoral Pathology +7

Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma

Naoya Yamazaki, Yoshio Kiyohara, Hisashi Uhara et al. · Cancer Science · 2017 · 124 citations · Full text

Cytokine Biomarkers, Immunology, Immunoediting +20

Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial

Chie Oshita, Masako Takikawa, Akiko Kume et al. · Oncology Reports · 2012 · 102 citations · Full text

Immunology, Dendritic Cell-based Vaccination, Immunodominance +22

Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients

Takeshi Nagashima, Ken Yamaguchi, Kenichi Urakami et al. · Cancer Science · 2019 · 89 citations · Full text

Engineering, Pathology, Cancer Registration +19